John J Sperzel III's Net Worth
$55.9 Thousand
Who is John J Sperzel III?
John J Sperzel III does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CHEMBIO DIAGNOSTICS, INC., T2 Biosystems, Inc., and Diadexus, Inc..
SEC CIK
John J Sperzel III's CIK is 0001602618
Past Insider Trading and Trends
2014 was John J Sperzel III's most active year for acquiring shares with 7 total transactions. John J Sperzel III's most active month to acquire stocks was the month of February. 2023 was John J Sperzel III's most active year for disposing of shares, totalling 4 transactions. John J Sperzel III's most active month to dispose stocks was the month of January. 2014 saw John J Sperzel III paying a total of $854,075.00 for 250,000 shares, this is the most they've acquired in one year. In 2022 John J Sperzel III cashed out on 474,893 shares for a total of $63,532.13, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CHEMBIO DIAGNOSTICS, INC. No price found
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +380.92% | 375K |
—
|
—
| 473.45K |
Jun 18
| |||
Form 4
|
∞
| 98.45K |
—
|
—
| 98.45K |
Oct 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
T2 Biosystems, Inc. (TTOO) Snapshot price: $2.94
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +20.12% | 67 |
—
|
—
| 400 |
Feb 24
| |||
Form 4
| +92.49% | 160 |
—
|
—
| 333 |
Feb 20
| |||
Form 4
| +290.73% | 12.89K |
$0.63 | -$6,178.57 | 17.33K |
Scheduled
|
Feb 20 - Feb 28
| ||
Form 4
| +15.64% | 30K |
$0.50 | $15,000.00 | 221.77K |
Apr 7
| |||
Form 4
|
∞
| 191.77K |
$0.45 | -$63,532.13 | 191.77K |
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Diadexus, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |